Kathleen J Motil1,2,3, Jane B Lane4,5, Judy O Barrish2,3, Fran Annese6, Suzanne Geerts5,7, Lauren McNair6, Steven A Skinner6, Jeffrey L Neul8, Daniel G Glaze2,3, Alan K Percy4,5. 1. USDA/ARS Children's Nutrition Research Center. 2. The Blue Bird Circle Rett Center. 3. Department of Pediatrics, Baylor College of Medicine, Houston, TX. 4. Civitan International Research Center. 5. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL. 6. Greenwood Genetic Center, Greenwood, SC. 7. Civitan-Sparks Clinics, University of Alabama at Birmingham, Birmingham, AL. 8. Vanderbilt University, Nashville, TN.
Abstract
OBJECTIVE: We reviewed medical records and conducted a nationwide survey to characterize the clinical features and determine the prevalence of biliary tract disease in girls and women with Rett syndrome (RTT). METHODS: Sixty-two individuals with RTT and biliary tract disease were identified from the membership of Rett Syndrome Organization and patient files of the principal investigator. Medical records of 46 individuals were reviewed for presenting features, diagnostic tests, and treatment outcomes of biliary tract disease. We designed a questionnaire that probed the frequency of risk factors and treatment outcomes of biliary tract disease in RTT. The questionnaire was completed by 271 parents whose daughters met the clinical criteria for RTT and/or had MECP2 mutations and participated in the Natural History of Rett Syndrome Study. RESULTS: Presenting symptoms identified by record review included abdominal pain (94%), irritability (88%), weight loss (64%), and vomiting (52%). Biliary dyskinesia, cholecystitis, and cholelithiasis were identified in 90%, 77%, and 70%, respectively, by cholescintigraphy, surgical pathology, and abdominal ultrasound. The prevalence of biliary tract disease was 4.4% (n = 12) in the RTT cohort. Risk factors included older age (P < 0.001) and a positive family history (P < 0.01). Diagnoses included cholecystitis (n = 5), biliary dyskinesia (n = 6), and cholelithiasis (n = 7). Ten individuals underwent surgery; 7 had resolution of symptoms after surgical intervention. CONCLUSIONS: Biliary tract disease is not unique to RTT, but may be under-recognized because of the cognitive impairment of affected individuals. Early diagnostic evaluation and intervention may improve the health and quality of life of individuals affected with RTT and biliary tract disease.
OBJECTIVE: We reviewed medical records and conducted a nationwide survey to characterize the clinical features and determine the prevalence of biliary tract disease in girls and women with Rett syndrome (RTT). METHODS: Sixty-two individuals with RTT and biliary tract disease were identified from the membership of Rett Syndrome Organization and patient files of the principal investigator. Medical records of 46 individuals were reviewed for presenting features, diagnostic tests, and treatment outcomes of biliary tract disease. We designed a questionnaire that probed the frequency of risk factors and treatment outcomes of biliary tract disease in RTT. The questionnaire was completed by 271 parents whose daughters met the clinical criteria for RTT and/or had MECP2 mutations and participated in the Natural History of Rett Syndrome Study. RESULTS: Presenting symptoms identified by record review included abdominal pain (94%), irritability (88%), weight loss (64%), and vomiting (52%). Biliary dyskinesia, cholecystitis, and cholelithiasis were identified in 90%, 77%, and 70%, respectively, by cholescintigraphy, surgical pathology, and abdominal ultrasound. The prevalence of biliary tract disease was 4.4% (n = 12) in the RTT cohort. Risk factors included older age (P < 0.001) and a positive family history (P < 0.01). Diagnoses included cholecystitis (n = 5), biliary dyskinesia (n = 6), and cholelithiasis (n = 7). Ten individuals underwent surgery; 7 had resolution of symptoms after surgical intervention. CONCLUSIONS:Biliary tract disease is not unique to RTT, but may be under-recognized because of the cognitive impairment of affected individuals. Early diagnostic evaluation and intervention may improve the health and quality of life of individuals affected with RTT and biliary tract disease.
Authors: R E Amir; I B Van den Veyver; R Schultz; D M Malicki; C Q Tran; E J Dahle; A Philippi; L Timar; A K Percy; K J Motil; O Lichtarge; E O Smith; D G Glaze; H Y Zoghbi Journal: Ann Neurol Date: 2000-05 Impact factor: 10.422
Authors: I Wesdorp; D Bosman; A de Graaff; D Aronson; F van der Blij; J Taminiau Journal: J Pediatr Gastroenterol Nutr Date: 2000-10 Impact factor: 2.839
Authors: Volker Kaechele; Martin Wabitsch; Dorothee Thiere; Alexandra Lydia Kessler; Mark Martin Haenle; Hermann Mayer; Wolfgang Kratzer Journal: J Pediatr Gastroenterol Nutr Date: 2006-01 Impact factor: 2.839
Authors: Crystal L Laurvick; Nicholas de Klerk; Carol Bower; John Christodoulou; David Ravine; Carolyn Ellaway; Sarah Williamson; Helen Leonard Journal: J Pediatr Date: 2006-03 Impact factor: 4.406
Authors: Cary Fu; Dallas Armstrong; Eric Marsh; David Lieberman; Kathleen Motil; Rochelle Witt; Shannon Standridge; Paige Nues; Jane Lane; Tristen Dinkel; Monica Coenraads; Jana von Hehn; Mary Jones; Katie Hale; Bernhard Suter; Daniel Glaze; Jeffrey Neul; Alan Percy; Timothy Benke Journal: BMJ Paediatr Open Date: 2020-09-13
Authors: Cary Fu; Dallas Armstrong; Eric Marsh; David Lieberman; Kathleen Motil; Rochelle Witt; Shannon Standridge; Jane Lane; Tristen Dinkel; Mary Jones; Katie Hale; Bernhard Suter; Daniel Glaze; Jeffrey Neul; Alan Percy; Timothy Benke Journal: BMJ Paediatr Open Date: 2020-09-22
Authors: Santosh Thapa; Alamelu Venkatachalam; Nabeel Khan; Mohammed Naqvi; Miriam Balderas; Jessica K Runge; Anthony Haag; Kathleen M Hoch; Daniel G Glaze; Ruth Ann Luna; Kathleen J Motil Journal: PLoS One Date: 2021-05-06 Impact factor: 3.240